The latest in funding & deals: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: Physioplus Healthcare raises seed round at $800K valuation.
North Immunology Reverse Merger Comes With $180M for Next-Gen Inflammation Drug
North Immunology is going public in a reverse merger with Aethlon Medical. With eczema as the lead indication, the inflammation and immunology biotech aims to show its bispecific antibody offers efficacy and tolerability advantages over Sanofi’s immune disorder juggernaut, Dupixent. The post North Immunology Reverse Merger Comes With $180M for Next-Gen Inflammation Drug appeared first on MedC…
Follow the full firehose on the HTC Wire, refreshed automatically every day.
Reach the people behind these stories. HealthTech Cube demand gen programs deliver qualified healthcare technology leads from $49.50 per lead - see packages or download the 2026 media kit.